XML 77 R52.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation (Narrative) (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 11, 2021
shares
Apr. 01, 2020
shares
Dec. 27, 2019
shares
Aug. 26, 2019
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
plan
$ / shares
shares
Mar. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2019
USD ($)
shares
Nov. 30, 2020
shares
Aug. 25, 2019
$ / shares
shares
Jun. 30, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of plans | plan         2          
Exercise price (in USD per share) | $ / shares         $ 9.90 $ 9.25        
Options vested and unvested outstanding (in shares)         8,293,331 7,723,302        
Options exercisable, Number of Options (in shares)         5,219,403 3,009,080 1,581,810      
Unrecognized compensation cost | $         $ 62.4          
Unrecognized compensation expense, period for recognition         2 years 10 months 24 days          
Share-based compensation expense from acceleration, modification and subsequent remeasurement of awards | $         $ 25.7          
Stock options repriced                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Repricing ratio       1            
Exercise price (in USD per share) | $ / shares       $ 7.78            
Options vested and unvested outstanding (in shares)                 5,095,013  
Stock-based compensation expense | $       $ 9.2            
Stock options repriced | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Exercise price (in USD per share) | $ / shares                 $ 8.82  
Stock options repriced | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Exercise price (in USD per share) | $ / shares                 24.44  
Stock options repriced | Median                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Exercise price (in USD per share) | $ / shares                 $ 17.28  
Stock options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Expiration period         10 years          
Accelerated vesting of awards (in shares) 631,850   849,212              
Restricted stock awards (unvested)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total fair value of awards vesed in period | $         $ 8.4 $ 1.4 $ 1.4      
Restricted stock units (unvested)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total fair value of awards vesed in period | $         3.3 0.2 $ 0.1      
Restricted Stock and Restricted Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting of awards (in shares) 761,770                  
Performance stock units (unvested)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting of awards (in shares) 301,659   108,640              
Total fair value of awards vesed in period | $         $ 3.6 0.8        
R&D expense                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting of awards | $           1.8        
SG&A expense                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Accelerated vesting of awards | $           $ 10.2        
Executives, Subject to Exercise Restriction Period | Stock options repriced                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vested executive options subject to one-year exercise restriction period (in shares)       735,428            
Restriction period       1 year            
Employee | Stock options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting term         4 years          
Director | Stock options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting term         3 years          
Annual vesting percentage         33.33%          
Quarterly vesting percentage         12.50%          
2020 Inducement Equity Award Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares reserved for grant (in shares)         100,000     1,000,000.0    
Myovant 2016 Equity Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares reserved for grant (in shares)         1,300,000         4,500,000
Common shares reserved for grant, annual percentage increase                   4.00%
Increase in common shares reserved for grant (in shares)   3,600,000